ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

EYEN Eyenovia Inc

0.6624
0.0403 (6.48%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 334,589
Bid Price 0.51
Ask Price 0.775
News (4)
Day High 0.6746

Low
0.501

52 Week Range

High
2.97

Day Low 0.62
Share Name Share Symbol Market Stock Type
Eyenovia Inc EYEN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0403 6.48% 0.6624 23:00:11
Open Price Low Price High Price Close Price Previous Close
0.62 0.62 0.6746 0.6309 0.6221
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
2,210 334,589 US$ 0.6428688 US$ 215,097 - 0.501 - 2.97
Last Trade Type Quantity Price Currency
18:53:34 formt 230 US$ 0.6624 USD

Eyenovia Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
27.8M 44.12M - 4k -27.26M -0.62 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Eyenovia News

Date Time Source News Article
6/14/202414:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/14/202414:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/14/202414:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
6/14/202407:40Edgar (US Regulatory)Form 8-K - Current report
6/04/202406:24Edgar (US Regulatory)Form 8-K - Current report
5/16/202416:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
5/16/202415:49Edgar (US Regulatory)Form 8-K - Current report
5/15/202415:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/06/202415:01Edgar (US Regulatory)Form ARS - Annual Report to Security Holders
3/18/202406:12IH Market NewsAnticipation Builds on Wall Street for Federal Reserve’s..
3/11/202407:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/14/202415:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EYEN Message Board. Create One! See More Posts on EYEN Message Board See More Message Board Posts

Historical EYEN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.77390.77970.610.6801718509,876-0.1115-14.41%
1 Month0.82210.86990.610.7295512520,172-0.1597-19.43%
3 Months1.181.200.5010.77702861,164,549-0.5176-43.86%
6 Months1.782.570.5011.22956,565-1.12-62.79%
1 Year2.882.970.5011.37632,919-2.22-77.00%
3 Years5.466.630.5012.24374,674-4.80-87.87%
5 Years4.897.720.5012.99329,957-4.23-86.45%

Eyenovia Description

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

Your Recent History

Delayed Upgrade Clock